Lifileucel, sold under the brand name Amtagvi, is a cellular therapy used for the treatment of melanoma. The most common adverse reactions include chills... 9 KB (590 words) - 19:55, 28 March 2024 |
rebranded to Iovance in 2017. In 2024 the US FDA gave accelerated approval to Lifileucel, the company's tumor-infiltrating lymphocyte drug for the treatment of... 3 KB (196 words) - 19:55, 28 March 2024 |
Eribulin Estramustine phosphate Glasdegib Idecabtagene vicleucel Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Oblimersen† Omacetaxine... 5 KB (313 words) - 21:41, 30 March 2024 |
Eribulin Estramustine phosphate Glasdegib Idecabtagene vicleucel Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Oblimersen† Omacetaxine... 9 KB (716 words) - 04:40, 3 April 2024 |